LawForumLawForum

The VIOXX Online Information Resource

Locate a Lawyer

Choosing a Lawyer

For Lawyers

Legal Resources

About the Law Forum



Info About VIOXX®

About VIOXX®
Health Risks
Legal Options
FAQs


Practice Areas

To locate an attorney to evaluate your case, choose from a practice area below:



Free Case Evaluation




VIOXX®
About VIOXX® - VIOXX® History

VIOXX® (rofecoxib), manufactured by Merck, was an extremely popular prescription arthritis and pain medication until Merck's voluntary market withdrawl of the drug in the fall of 2004.

FDA Approval and Skyrocketing Sales
In 1999, Merck received FDA approval for VIOXX® as a treatment for pain from osteoarthritis, acute pain in adults, and menstrual pain. VIOXX® quickly became a mega-drug, being prescribed to nearly 25 million people by 2000* and accounting for nearly $2.5 billion in sales in 2003. Much of the drug's explosive sales was attributed to Merck's aggressive consumer and physician advertising tactics. In 2002 alone, Merck spent more than $171 million to promote VIOXX®.

VIGOR Safety Study and FDA Label Changes
In June 2000, while studying the gastrointestinal effects of VIOXX® in a study called VIGOR (VIOXX® Gastrointestinal Outcomes Research), Merck researchers found that patients taking VIOXX® (rofecoxib) exhibited an increased risk of serious cardiovascular events (i.e., heart attacks and strokes).

In September 2001, the FDA the FDA issued a warning to Merck for misrepresenting the safety of VIOXX® by downplaying the cardiovascular risks associated with the drug's use.

Then in April 2002, under the direction of the FDA, Merck implemented labeling changes to include information about the increase in risk of cardiovascular events, including heart attack and stroke.

APPROVe Trial & VIOXX®'s Market Withdrawl
In 2004, while studying VIOXX®'s ability to decrease the risk of developing recurrent colon polyps (the APPROVe Trial), findings once again demonstrated an increased risk of serious heart attacks and strokes for patients on the drug. These findings, combined with findings from other recent research studies about VIOXX®'s cardiovascular safety, led Merck to voluntarily withdraw the drug from the market on September 30, 2004.

If you or a loved one has suffered a heart attack, heart arrhythmia, stroke or sudden cardiac death while taking Vioxx® and have questions about your legal rights, fill out our free case evaluation form.

* source: July 2000 Kaiser poll



Choose the state where you live to locate a Vioxx lawyer near you.

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington, D.C.
West Virginia
Wisconsin
Wyoming







Locate a Lawyer   |   Choosing a Lawyer   |   For Lawyers   |   Exchange Links   |   About the Law Forum


LawForum
Copyright © 2004 LawForum. All rights reserved.